🇺🇸 Byetta (Exenatide) in United States
177 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 177
Most-reported reactions
- Blood Glucose Increased — 36 reports (20.34%)
- Nausea — 23 reports (12.99%)
- Weight Decreased — 19 reports (10.73%)
- Bladder Cancer — 17 reports (9.6%)
- Blood Glucose Decreased — 16 reports (9.04%)
- Pancreatitis — 15 reports (8.47%)
- Pancreatitis Acute — 14 reports (7.91%)
- Renal Failure — 14 reports (7.91%)
- Malaise — 12 reports (6.78%)
- Vomiting — 11 reports (6.21%)
Other Diabetes approved in United States
Frequently asked questions
Is Byetta (Exenatide) approved in United States?
Byetta (Exenatide) does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Byetta (Exenatide) in United States?
Beijing Chao Yang Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.